A New Option for Some People With Lung Cancer: What the Approval of Lorlatinib Means for Patients

A New Option for Some People With Lung Cancer: What the Approval of Lorlatinib Means for Patients

The FDA recently approved the drug lorlatinib for the treatment of some non-small cell lung cancer. Doctors talk to SurvivorNet about the significance of this approval.

NOW
PLAYING
Amtagvi Shows Promise For Treating Metastatic Melanoma
NOW
PLAYING
FDA Approves Tepotinib for Metastatic Non-Small Cell Lung Cancer
NOW
PLAYING
What It's Like To Get Molecular Testing for Lung Cancer
NOW
PLAYING
Next-Generation Sequencing (NGS) Helps Identify Exact Mutations in Lung Cancer
NOW
PLAYING
Molecular Testing for Lung Cancer
NOW
PLAYING
"Dharma & Greg" Star Susan Sullivan, 81, Says It's An 'Enormous Blessing' To Be Cancer Free After Lung Cancer Surgery— How She Stayed Positive Through Adversity

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... lung cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.